Delivery Order SPE2DB20D7066-SPE2DB25FC4DA
Award Date 7/22/25
Potential Completion Date 7/23/25
Potential Value $1.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $3,091.99 to AmerisourceBergen Drug Corp for the supply of Adenosine 12 mg/4 mL syringes on August 22, 2025, with completion expected by August 25, 2025. This firm fixed-price delivery order is being fulfilled from the company's place of performance in Conshohocken, Pennsylvania, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Adenosine 12 mg/4 mL syringes with a ceiling value of $1,027.81. This non-competitive delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 26, 2025. The contract utilizes firm fixed pricing under a delivery order arrangement, representing a...
- The Defense Logistics Agency awarded a $3,957.51 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Adenosine 6 mg/2 mL syringes. This firm fixed price contract, with an ultimate completion date of September 17, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The performance location is AmerisourceBergen's...
- The Defense Logistics Agency awarded a $3,993.45 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Adenosine 12 mg/4 ml syringes. The contract, which is not set-aside and competitively awarded, represents a firm fixed price delivery order with an ultimate completion date of August 26, 2025. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $1,136.88 delivery order to AmerisourceBergen Drug Corp for the supply of Adenosine 12 mg/4 mL vials on July 18, 2025, with completion targeted for July 21, 2025. The award utilizes firm fixed pricing with no set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Adenosine 12 mg/4 mL vials with a ceiling value of $1,084.19. This is a firm fixed-price delivery order with an ultimate completion date of July 21, 2025, and no set-aside designation was used in the award. The work will be performed at the vendor's location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $1,917.45 firm fixed price delivery order is for the supply of 4,564,214,621 units of Adenosine 6 mg/2 ml syringes, with a period of performance through April 10, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,580,139 adenosine 12 mg/4 ml syringes. The contract has a completion date of February 8, 2024 and a potential value of $2,309.08. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) with DLA valued at up to...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,982.37 firm fixed-price contract is for the supply of 4,566,929,738 units of Adenosine 12 mg/4 ml syringes. The contract has an ultimate completion date of January 15, 2025 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adenosine 12mg/4ml (10 units) on August 21, 2025. This firm fixed price delivery order, valued at $2,154.70, represents a competitively awarded, non-set-aside contract with a place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order is issued under AmerisourceBergen's larger Indefinite...